• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含功能化二茂铁基β-二酮配体的钌(II)芳烃配合物的细胞毒性

Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands.

作者信息

Allison Matthew, Caramés-Méndez Pablo, Hofmann Benjamin J, Pask Christopher M, Phillips Roger M, Lord Rianne M, McGowan Patrick C

机构信息

School of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.

Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, U.K.

出版信息

Organometallics. 2023 Jul 5;42(15):1869-1881. doi: 10.1021/acs.organomet.2c00553. eCollection 2023 Aug 14.

DOI:10.1021/acs.organomet.2c00553
PMID:37592952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10428205/
Abstract

The synthesis and characterization of 24 ruthenium(II) arene complexes of the type [(-cym)RuCl(Fc-acac)] (where -cym = p-cymene and Fc-acac = functionalized ferrocenyl β-diketonate ligands) are reported, including single-crystal X-ray diffraction for 21 new complexes. Chemosensitivity studies have been conducted against human pancreatic carcinoma (MIA PaCa-2), human colorectal adenocarcinoma -wildtype (HCT116 ) and normal human retinal epithelial cell lines (APRE-19). The most active complex, which contains a 2-furan-substituted ligand (), is 5x more cytotoxic than the analogs 3-furan complex () against MIA PaCa-2. Several complexes were screened under hypoxic conditions and at shorter-time incubations, and their ability to damage DNA was determined by the comet assay. Compounds were also screened for their potential to inhibit the growth of both bacterial and fungal strains.

摘要

报道了24种[(-cym)RuCl(Fc-acac)]类型的钌(II)芳烃配合物(其中-cym = 对异丙基苯,Fc-acac = 功能化二茂铁基β-二酮配体)的合成与表征,包括对21种新配合物的单晶X射线衍射分析。已针对人胰腺癌(MIA PaCa-2)、人结肠直肠腺癌野生型(HCT116)和正常人视网膜上皮细胞系(APRE-19)进行了化学敏感性研究。活性最高的配合物含有2-呋喃取代配体(),对MIA PaCa-2的细胞毒性比3-呋喃类似物配合物()高5倍。在缺氧条件下和较短孵育时间下对几种配合物进行了筛选,并通过彗星试验测定了它们损伤DNA的能力。还筛选了化合物抑制细菌和真菌菌株生长的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/d455525d3f22/om2c00553_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/aef8ab03240d/om2c00553_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/27217caca380/om2c00553_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/80c782862859/om2c00553_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/de3b2934cce4/om2c00553_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/be5de0f652a7/om2c00553_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/28e536a33022/om2c00553_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/ee5382ebe185/om2c00553_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/d455525d3f22/om2c00553_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/aef8ab03240d/om2c00553_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/27217caca380/om2c00553_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/80c782862859/om2c00553_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/de3b2934cce4/om2c00553_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/be5de0f652a7/om2c00553_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/28e536a33022/om2c00553_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/ee5382ebe185/om2c00553_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa57/10428205/d455525d3f22/om2c00553_0008.jpg

相似文献

1
Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands.含功能化二茂铁基β-二酮配体的钌(II)芳烃配合物的细胞毒性
Organometallics. 2023 Jul 5;42(15):1869-1881. doi: 10.1021/acs.organomet.2c00553. eCollection 2023 Aug 14.
2
Bis(bipyridine)ruthenium(II) Ferrocenyl β-Diketonate Complexes: Exhibiting Nanomolar Potency against Human Cancer Cell Lines.双(联吡啶)钌(II)二茂铁β-二酮配合物:对人癌细胞系具有纳摩尔效力。
Chemistry. 2021 Feb 19;27(11):3737-3744. doi: 10.1002/chem.202004024. Epub 2021 Jan 19.
3
Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.含有O,O-螯合配体的细胞毒性钌芳烃配合物的氯代、水合、9-乙基鸟嘌呤和9-乙基腺嘌呤加合物。
J Inorg Biochem. 2007 Nov;101(11-12):1903-12. doi: 10.1016/j.jinorgbio.2007.04.018. Epub 2007 May 10.
4
Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.基于钌(II)芳烃配合物与2-芳基二唑配体的抗癌特性推导构效关系
Inorg Chem. 2014 Oct 20;53(20):11274-88. doi: 10.1021/ic501865h. Epub 2014 Oct 10.
5
New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.含有卤素取代的双(吡唑-1-基)硼酸酯和三(吡唑-1-基)硼酸酯配体的新型钌(芳烃)配合物。
Chemistry. 2014 Mar 24;20(13):3689-704. doi: 10.1002/chem.201304406. Epub 2014 Feb 24.
6
β-Diketonate versus β-Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency.β-二酮酸酯与β-酮亚胺酸酯:二茂铁基在提高抗癌活性方面的重要性。
Chembiochem. 2020 Jul 16;21(14):1988-1996. doi: 10.1002/cbic.202000028. Epub 2020 Apr 2.
7
Ruthenium -Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.钌-苎烯配合物,引入取代吡啶-喹啉基配体:合成、表征和细胞毒性性质。
Molecules. 2024 Jul 6;29(13):3215. doi: 10.3390/molecules29133215.
8
Evaluation of biomolecular interactions and cytotoxic activity of organometallic binuclear Ru(II) complexes of ferrocenyl thiosemicarbazones.评估二茂铁基硫代缩氨基脲的双金属有机双核 Ru(II) 配合物的生物分子相互作用和细胞毒性活性。
J Biomol Struct Dyn. 2021 Oct;39(16):6044-6055. doi: 10.1080/07391102.2020.1798284. Epub 2020 Jul 30.
9
,-Ru(II)--cymene-poly(-vinylpyrrolidone) surface functionalized gold nanoparticles: from organoruthenium complex to nanomaterial for antiproliferative activity.-钌(II)-对异丙基苯-聚(乙烯基吡咯烷酮)表面功能化金纳米粒子:从有机钌配合物到具有抗增殖活性的纳米材料
Dalton Trans. 2021 Jun 15;50(23):8232-8242. doi: 10.1039/d1dt00694k.
10
Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.双嘧啶钌(II)芳环配合物:结构、反应性和细胞毒性。
J Biol Inorg Chem. 2012 Oct;17(7):1033-51. doi: 10.1007/s00775-012-0917-9. Epub 2012 Jul 12.

引用本文的文献

1
Ruthenium -Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.钌-苎烯配合物,引入取代吡啶-喹啉基配体:合成、表征和细胞毒性性质。
Molecules. 2024 Jul 6;29(13):3215. doi: 10.3390/molecules29133215.

本文引用的文献

1
Potent Ruthenium-Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to Evaluation in Zebrafish.强效钌-二茂铁双金属抗肿瘤抗血管生成剂,可规避铂耐药性:从合成和机制研究到斑马鱼评估。
J Med Chem. 2022 Dec 22;65(24):16353-16371. doi: 10.1021/acs.jmedchem.2c01174. Epub 2022 Dec 2.
2
Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients.肿瘤缺氧:癌症患者顺铂耐药的主要元凶。
Crit Rev Oncol Hematol. 2021 Jun;162:103327. doi: 10.1016/j.critrevonc.2021.103327. Epub 2021 Apr 20.
3
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
钌配合物作为抗癌剂:简要的历史和展望。
Drug Des Devel Ther. 2020 Dec 3;14:5375-5392. doi: 10.2147/DDDT.S275007. eCollection 2020.
4
Bis(bipyridine)ruthenium(II) Ferrocenyl β-Diketonate Complexes: Exhibiting Nanomolar Potency against Human Cancer Cell Lines.双(联吡啶)钌(II)二茂铁β-二酮配合物:对人癌细胞系具有纳摩尔效力。
Chemistry. 2021 Feb 19;27(11):3737-3744. doi: 10.1002/chem.202004024. Epub 2021 Jan 19.
5
β-Diketonate versus β-Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency.β-二酮酸酯与β-酮亚胺酸酯:二茂铁基在提高抗癌活性方面的重要性。
Chembiochem. 2020 Jul 16;21(14):1988-1996. doi: 10.1002/cbic.202000028. Epub 2020 Apr 2.
6
Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.缺氧通过 HIF-1α/miR-338-5p/IL-6 反馈环诱导结直肠癌耐药。
Mol Ther. 2019 Oct 2;27(10):1810-1824. doi: 10.1016/j.ymthe.2019.05.017. Epub 2019 Jun 4.
7
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry.NAMI-A 和 KP1019/1339,两个标志性的钌类抗癌候选药物面对面:药物无机化学的案例研究。
Molecules. 2019 May 24;24(10):1995. doi: 10.3390/molecules24101995.
8
Hypoxia exposure induced cisplatin resistance partially via activating p53 and hypoxia inducible factor-1α in non-small cell lung cancer A549 cells.低氧暴露通过激活非小细胞肺癌A549细胞中的p53和缺氧诱导因子-1α部分诱导顺铂耐药。
Oncol Lett. 2018 Jul;16(1):801-808. doi: 10.3892/ol.2018.8767. Epub 2018 May 22.
9
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.抗癌钌(II)配合物的发展:从单分子化合物到纳米材料。
Chem Soc Rev. 2017 Oct 2;46(19):5771-5804. doi: 10.1039/c7cs00195a.
10
Synthesis and Structural Evaluation of Organo-Ruthenium Complexes with β-Diketonates.含β-二酮酸酯的有机钌配合物的合成与结构评估
Molecules. 2017 Feb 20;22(2):326. doi: 10.3390/molecules22020326.